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We identified the Grb7 family members, Grb10 and Grb14, as Ca2+-dependent
CaM-binding proteins using Ca2+-dependent CaM-affinity chromatography as
we previously did with Grb7. The potential CaM-binding sites were identified
and experimentally tested using fluorescent-labeled peptides corresponding to
these sites. The apparent affinity constant of these peptides for CaM, and the
minimum number of calcium ions bound to CaM that are required for effective
binding to these peptides were also determined. We prepared deletion mutants
of the three adaptor proteins lacking the identified sites and determined that
they lost or strongly diminished their CaM-binding capacity following the
sequence Grb7 > > Grb14 > Grb10. More than one CaM-binding site and/or
accessory CaM-binding sites appear to exist in Grb10 and Grb14, as compared
to a single one present in Grb7.
Keywords: adaptor proteins; calmodulin; calmodulin-binding sites; Grb10;
Grb14; Grb7
The growth factor receptor bound proteins 7, 10 and 14
(Grb7, Grb10 and Grb14) form a family of mammalian
adaptor proteins that play important roles mediating
the transmission of signals from tyrosine kinase recep-
tors and nonreceptor tyrosine kinases by coupling pro-
tein complexes to attain cellular responses [1–6]. These
proteins are phylogenetically related to the Caenorhab-
ditis elegans Mig10 protein, which is involved in the
regulation of embryonic neural cell migration [7,8].
They all share significant sequence homology and a
well-conserved modular structure divided into several
domains: a proline-rich (PR) domain in the N-terminal,
a central GM region (for Grb and Mig10) comprising a
Ras-associating (RA) domain, a pleckstrin homology
(PH) domain and a BPS domain (for between PH and
SH2); and finally a Src homology 2 (SH2) domain
located in the C-terminal [1–3,5].
Grb7 is implicated in cell migration processes by inter-
acting with focal adhesion kinase by an integrin-mediated
mechanism [9] and with the ephrin type-B receptor 1
Abbreviations
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[10]. In tumor cells, coexpression of Grb7 with the tyr-
osine kinase receptor ErbB2, and its natural occurring
variant Grb7V lacking the SH2 domain, contribute to
tumor cells invasiveness and metastasis formation [11–
13]. In addition, Grb7 also plays important roles in
cell proliferation [14,15], cell adhesion [16] and tumor-
associated angiogenesis [15,17].
Several isoforms of the human Grb10 generated by
alternative splicing have been described, including
hGrb10a, hGrb10b and hGrb10c [2], the hGrb10c iso-
form being the longest [18,19]. The hGrb10a isoform
is shorter and lacks a 46 amino acids long section cor-
responding to the PH domain [19,20]. The hGrb10b
isoform differs from the hGrb10a isoform in the 50-
UTR and in the 50 coding region, and although has an
intact PH domain as the hGrb10c isoform, it has a
shorter N-terminal region [21]. These isoforms differ in
their expression pattern, which seems to be tissue-
specific [22,23]. Although Grb10 has been found to
interact with different tyrosine-kinase receptors includ-
ing the epidermal growth factor receptor (EGFR) [1],
EphB1/ELK [24], platelet-derived growth factor recep-
tor [21] and vascular endothelial growth factor recep-
tor [25], and nonreceptor tyrosine kinases including
Tec [26] and Bcr-Abl [27], its most important described
role is to bind with high affinity to the insulin receptor
[19,28] and the insulin-like growth factor 1 receptor
(IGF-1R) [20,29–33] causing the inhibition of these
receptors upon ligand stimulation. Besides, Grb10 has
been found to interact with the ubiquitin ligase Nedd4
[34] triggering the internalization and degradation of
the IGF-1R [35].
Grb14 was first identified in human breast epithelial
cells [36]. This adaptor protein was also found to inhibit
the insulin receptor and IGF-1R after insulin stimula-
tion mediating the coordinated downregulation of the
receptors [37]. This interaction was mediated by the
BPS domain of Grb14 inhibiting the catalytic activity
of the receptor, process that was enhanced by the SH2
domain of the adaptor protein [38,39]. The GRB14 gene
is overexpressed in breast and prostate tumors [36,40],
and several mutations occurring with high frequency in
human colorectal cancers have been described [41].
Calmodulin (CaM) is a ubiquitous Ca2+-receptor
protein in all eukaryotic cells that transduces intracel-
lular Ca2+ signals generated by a variety of biological
effectors (e.g. growth factors, hormones, neurotrans-
mitters) or physical stimulus (e.g. mechanical, light,
temperature) regulating hundreds of enzymes and
nonenzymatic proteins implicated in the control of
multiple cellular functions [42–46]. In addition, Ca2+-
free CaM (apo-CaM) is also able to regulate a variety
of target proteins [47]. We have previously
demonstrated in vitro and in living cells Ca2+-depen-
dent binding of CaM to human Grb7 and identified its
CaM-binding domain (CaM-BD) located at the proxi-
mal region of the PH domain comprising the sequence
243RKLWKRFFCFLRRS256 [17]. The deletion of this
site affects Grb7-mediated cellular functions including
its nuclear translocation, cell attachment, cell migra-
tion, tumor growth and tumor-associated angiogenesis
[15–17,48]. In this report, we demonstrate that Grb10
and Grb14 are also Ca2+-dependent CaM-binding
proteins and identify the location of their CaM-BDs
using deletion mutants.
Materials and Methods
Reagents
Anti-FLAG-M2 (clone M2, isotype IgG1) mouse mono-
clonal antibody was purchased from Sigma-Aldrich Co
(St. Louis, MO, USA). Anti-HA tag rabbit monoclonal
antibody was from Upstate-Millipore (Billerica, MA,
USA). Anti-Grb7 (N-20) rabbit polyclonal antibody was
purchased from Santa Cruz Biotechnology (Dallas, TX,
USA). Anti-Grb10 mouse monoclonal and anti-Grb14
rabbit polyclonal antibodies were obtained from ABCAM
(Cambridge, UK). Anti-rabbit immunoglobulin G (IgG)
goat polyclonal antibody coupled to horseradish peroxi-
dase was purchased from Zymed Laboratories Inc. (San
Francisco, CA, USA), Invitrogen (Carlsbad, CA, USA) or
GE Healthcare-Amersham (Little Chalfont, UK), and the
anti-mouse Fc-specific IgG polyclonal (goat) secondary
antibody coupled to horseradish peroxidase was obtained
from Sigma-Aldrich Co. or GE Healthcare-Amersham.
Polyvinylidene difluoride (PVDF) membranes were
obtained from Pall Co. (New York, NY, USA), and Dul-
becco’s modified Eagle’s medium (DMEM), fetal bovine
serum (FBS), trypsin/EDTA solution and L-glutamine
were purchased from Invitrogen. The enhanced chemilumi-
nescence (ECL) kit and CaM-Sepharose 4B were obtained
from GE Healthcare-Amersham, and the X-ray films were
from Konika Minolta (Tokyo, Japan). Triton X-100, ethy-
lene glycol-bis(2-aminoethylether)-N,N,N0,N0-tetraacetic acid
(EGTA), trichloroacetic acid and phenylmethylsulfonyl fluo-
ride (PMSF) were purchased from Sigma-Aldrich Co. The
protease inhibitors cocktail (set III) was from Merck-Calbio-
chem (Darmstadt, Germany), and Tween-20, acrylamide/
bis-acrylamide solution and precision Plus Protein Standards
were purchased from Bio-Rad (Hercules, CA, USA). The
ExSiteTM mutagenesis kit was obtained from Stratagene (San
Diego, CA, USA), and the Genopure plasmid maxi kit was
obtained from Roche Life Science (Basel, Switzerland).
Lipofectamine 2000 was purchased from Life Technologies
(Carlsbad, CA, USA). The three synthetic peptides labeled
with tetramethylrhodamine (TAMRA) corresponding
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to the CaM-BD of hGrb7 (RKLWKRFFCFLRRS),
hGrb10c (KKSWKKLYVCLRRS) and hGrb14
(KKSWKKIYFFLRRS) were synthesized by Schafer-N
(Copenhagen, Denmark). Other reagents used in this work
were of analytical grade.
Vectors preparation
The pCR3/FLAG-Grb7 vector was kindly donated by S.
Tanaka (Kyushu University, Japan), and its open reading
frame (ORF) was amplified by polymerase chain reaction
(PCR) as previously described [17] using the following
oligonucleotides: forward primer 50-GAT GAC GAT CAT
ATG GAG CCG GAT CTG TCT CCA CCT CAT C-30
containing a NdeI restriction site (underlined) and reverse
primer 50-GCC AGT CCA CGC TCG AGT CAG AGG
GCC ACC CGC GTG CAG C-30, containing a XhoI
restriction site (underlined). The PCR product was sub-
cloned into the bacterial expression vector pET-14b to
obtain pET-Grb7. Additionally, the CaM-BD (residues
243–256) deletion mutant denoted Grb7Δ was generated by
mutagenesis using the ExSiteTM mutagenesis kit, the vectors
pCR3/FLAG-Grb7 and pET-Grb7 as templates and the
following oligonucleotides: forward 50-TCC TGA ACC
CCG CAG CTG CAG AAA GCC CTG-30 and reverse 50-
GGC GTC TAT TAC TCC ACC AAG GGC ACC TCT
AAG-30. Alternatively, EcoRI and XhoI restriction enzymes
were used to subclone FLAG-Grb7 and FLAG-Grb7Δ into
pcDNA3.1, yielding the pcDNA3/FLAG-Grb7 and
pcDNA3/FLAG-Grb7Δ vectors.
The pCDNA3/Grb10c-HA vector was kindly provided
by S. Gioretti-Peraldi (INSERM, Faculty of Medicine,
Nice, France) and was used as a template to obtain
pcDNA3/Grb10Δ-HA with the ExSiteTM mutagenesis kit
and the following oligonucleotides: forward 50-GCA TGT
GAA AGA GCT GGG-30 and reverse 50-CTT TGA AGT
TCC CTT GGT G-30. Three different deletion mutants
(termed Grb10Δ1, Grb10Δ2 and Grb10Δ3) were prepared
by removing the nucleotides corresponding to the residues
246RKNYAKYEFFKN257, 304KKSWKKLYVCLRRS317
or 387RTCWMTAFRLLK398, respectively. In the case of
Grb10Δ2, the sequence was chosen on the basis to its simi-
larity to the CaM-binding domain of Grb7
(243RKLWKRFFCFLRRS256) [17], and in the case of
Grb10Δ1 and Grb10Δ3 using a software for predicting
CaM-BDs (freely available at http://calcium.uhnres.utoron
to.ca). Each single mutant was constructed using two PCR
reactions, and directional ligation (subcloning) of resulting
amplicons to pcDNA3. PCR reactions were done using
Vent (New England Biolabs, Ipswich, MA, USA) poly-
merase to generate high fidelity blunt-ended amplicons, and
pcDNA3-Grb10c-HA as a template, to allow subcloning in
the same plasmid backbone. Primers for the first PCR were
designed to generate a 50-most gene fragment, beginning at
the unique HindIII restriction site of pcDNA3 (forward
primer: 50-ATA CGA CTC ACT ATA GGG AGA C-30)
and ending just before the Grb10c region to be deleted (re-
verse primer: 50-GAA TAG AAA TTT ACTCTC ACT G-
30 for Grb10Δ1, and 50-GGT TTG CTC GTC CTC TGC-
30 for Grb10Δ3). Primers for the second PCR were
designed to generate a 30-most gene fragment, beginning
just after the Grb10c region to be deleted (forward primer:
50-CCC ATG AAT TTC TTC CCA GAA-30 for Grb10Δ1,
and 50-TAT GGA ATG CTC CTT TAC CAG -3 for
Grb10Δ3) and ending at the unique ApaI restriction site of
pcDNA3 (reverse primer: 50-TAG CAT TTA GGT GAC
TCT ATA G-30). Directional subcloning was achieved by
mixing in the same ligation reaction (containing T4 ligase
provided by New England Biolabs) three DNA substrates:
pcDNA3 (HindII and ApaI restriction digested), 50-most
amplicon (HindII restriction digested), and 30-most amplicon
(ApaI restriction digested). Note that the 50-most and 30-most
amplicons ligate to pcDNA3 through their different cohesive
ends, and that the 50-most and 30-most amplicons ligated to
each other through their blunt ends. The double mutants
Grb10Δ1Δ2 and Grb10Δ2Δ3 were constructed following the
same strategy but using a precedent deletion mutant back-
bone as a template for second rounds of PCR and ligation.
The pRc/CMV/Grb14-FLAG vector was kindly donated
by R. J. Daly (Monash University, Vic., Australia) and the
pRc/CMV/Grb14Δ-FLAG vector was prepared amplifying
the ORF of Grb14 using pRc/CMV/Grb14-FLAG as a
template and the forward primer 50-ATG ACC ACT TCC
CTG CAA GAT G-30. The PCR product was cloned into
pMOSBlue plasmid and used as a template for PCR-aided
mutagenesis using the forward primer 50-GGT TTA TAT
TTT TCT ACT AAA GGA AC-30 and the reverse primer
50-TCC CTG TTC TTT CGC ATG TAA GA-30. The PCR
product was purified and religated in the pMOSBlue vec-
tor. Finally, the Grb14Δ insert was subcloned into the
pRC/CMV/FLAG vector using the NdeI and EcoRI restric-
tion enzymes. Vectors replication was performed in trans-
formed Escherichia coli DH5a grown in Luria-Bertani
broth with 0.1 mgmL1 ampicillin. The isolation of the
vectors was performed following the low-copy number pro-
cedure of the Genopure plasmid maxi kit.
Cells culture
Authenticated human embryonic kidney (HEK) 293 cells
(ATCC number CRL-1573TM) were obtained from the
American Type Culture Collection (Manassas, VA, USA).
The cells were grown in DMEM supplemented with 10%
(v/v) FBS, 2 mM L-glutamine, 40 lgmL1 gentamicin at
37 °C in a humidified atmosphere of air containing 5% CO2.
Cells transfection
The HEK293 cells were transfected with the following plas-
mids: pcDNA3.1 (empty vector), pcDNA3/FLAG-Grb7,
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pcDNA3/FLAG-Grb7Δ, pCDNA3/Grb10c-HA, pCDNA3/
Grb10cΔ1-HA, pCDNA3/Grb10cΔ2-HA, pCDNA3/
Grb10cΔ3-HA, pCDNA3/Grb10cΔ1Δ2-HA, pCDNA3/
Grb10cΔ2Δ3-HA, pRc/CMV/Grb14-FLAG and pRc/
CMV/Grb14Δ-FLAG with the calcium phosphate method
as described [17] or the Lipofectamine 2000 method
following the instructions of the manufacturer.
Electrophoresis and western blot
Proteins were electrophoretically separated in 5–20% (w/v)
polyacrylamide gradient slab gels in the presence of 0.1%
(w/v) SDS at pH 8.3 [49] during 16–17 h at 6 mA. Proteins
were electrotransferred from the gels to PVDF membranes
for 2 h at 400 mA in a buffer containing 48 mM Tris-base,
36.6 mM L-glycine, 0.04% (w/v) SDS and 20% (v/v) metha-
nol (TGSM buffer). Proteins were fixed with 0.2% (v/v)
glutaraldehyde in 10 mM Tris-HCl (pH 8) and 150 mM
NaCl (TBS buffer) for 10 min; and transiently stained with
a 0.1% (w/v) Fast Green FCF solution in 50% (v/v)
methanol and 10% (v/v) acetic acid to verify the regularity
of the transfer procedure. The membranes were blocked
with 5% (w/v) BSA or 5% (w/v) fat-free powdered milk
according to the instructions of the antibodies’ manufactur-
ers in TBS containing 0.1% (v/v) Tween-20 (TBS-T buffer)
and incubated overnight at 4 °C using a 1/2000 dilution of
the corresponding primary antibody. Membranes were
incubated thereafter for 1 h at room temperature using a 1/
5000 dilution of the appropriate secondary antibody cou-
pled to horseradish peroxidase. The positive bands were
developed using the ECL reagents following instructions
from the manufacturer.
Calmodulin-affinity chromatography
Ca2+-dependent CaM-affinity chromatography was per-
formed as previously described [17]. Briefly, cells were
washed twice with cold PBS (130 mM NaCl, 2.7 mM KCl,
11.5 mM sodium/potassium phosphate pH 7.4) and resus-
pended in a buffer containing 20 mM Hepes-NaOH (pH
7.5), 150 mM NaCl, and the protease inhibitor cocktail sup-
plemented with freshly prepared 1 mM PMSF. The cells
were sonicated on ice for 5 min with 15 s on/off pulses and
centrifuged at 100 000 g for 30 min at 4 °C. An aliquot of
the supernatant was kept and processed by polyacrylamide
gel electrophoresis in the presence of sodium dodecyl sul-
fate (SDS/PAGE) and western blot to have a positive con-
trol for input in the column. CaCl2 was added to the rest
of the supernatant at a final concentration of 100 lM and
the sample was passed through a 1–2 mL bed volume
CaM-Sepharose 4B column previously equilibrated with
25 mM Hepes-NaOH (pH 7.5), 135 mM NaCl, 100 lM
CaCl2, and the protease inhibitor cocktail supplemented
with freshly prepared 1 mM PMSF (Ca2+-buffer). After
extensively washing with the same buffer, 0.5 mL fractions
were collected before and after elution with a buffer con-
taining 25 mM Hepes-NaOH (pH 7.5), 135 mM NaCl,
2 mM EGTA, and the protease inhibitor cocktail supple-
mented with freshly prepared 1 mM PMSF (EGTA-buffer).
The proteins in the fractions were precipitated with 10%
(w/v) TCA and processed by SDS/PAGE and western blot
as previously described.
Calmodulin binding to peptides upon addition of
different calcium concentrations
Peptides were tagged with the fluorescent dye TAMRA.
The binding of the tagged peptides to CaM was followed
by fluorescence anisotropy in a medium of known changing
free Ca2+ concentrations. Exhaustive description of the
methodology used was previously described [50].
Results
Our laboratory previously described the presence of a
CaM-BD in hGrb7 comprising the sequence
243RKLWKRFFCFLRRS256 located in the proximal
region of the PH domain, and found that this adaptor
protein was able to bind CaM in a Ca2+-dependent
manner both in vitro and in living cells. To study the
functionality of the CaM-BD of Grb7, we prepared a
deletion mutant named Grb7Δ lacking the CaM-BD,
and diverse techniques were used to ascertain its
inability to bind CaM [17].
Sequence analysis of Grb10 and Grb14 in several
species showed that they have significant sequence
homology and a well-conserved molecular structure
with that of Grb7. When we compared the CaM-BD
of hGrb7 with the sequences of hGrb10b/hGrb10c and
hGrb14, we observed significant homology with the
segments 246KKSWKKLYVCLRRS259 in hGrb10c,
304KKSWKKLYVCLRRS317 in hGrb10b and
248KKSWKKIYFFLRRS261 in hGrb14 (Table 1).
To study whether Grb10 and Grb14 are also CaM-
BPs as Grb7, we generated deletion mutants lacking
the indicated segments, respectively, denoted by
Grb7Δ, Grb10Δ and Grb14Δ. The expression of the
wild-type proteins and their respective deletion
mutants in transfected HEK293 cells show the
expected increase in electrophoretic mobility of the
mutants (Fig. 1A). The cytosolic fractions of HEK293
cells transiently transfected with pcDNA3/Grb10c-HA
or pcDNA3/FLAG-Grb14 were applied to a CaM-
Sepharose 4B column equilibrated with a buffer con-
taining Ca2+. After extensive washing with the Ca2+
buffer, the bound proteins were eluted with an EGTA-
containing buffer. We also processed an aliquot of the
cytosolic fraction as a positive control. The different
fractions were separated by SDS/PAGE, transferred to
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PVDF and probed with specific antibodies. Figure 1B
shows that both wild-type Grb10 and Grb14 were
detected in the EGTA-eluted fractions, as was the case
for wild-type Grb7, suggesting Ca2+-dependent bind
to CaM. Once we identified the three Grb7 family
members as CaM-BPs (Ref. [17] and Fig. 1B), and as
the sequence homology of the putative CaM-BDs of
the three proteins were notorious (Table 1), we tested
whether the mutants lost their ability to bind CaM.
We prepared cytosolic fractions of cells transiently
transfected with pcDNA3/FLAG-Grb7Δ, pcDNA3/
Grb10Δ-HA or pcDNA3/FLAG-Grb14Δ and sub-
jected them to Ca2+-dependent CaM-affinity chro-
matography as previously described. We determined
the comparative behavior of the three deletion mutants
in the column. Western blot analysis demonstrated
that although Grb10Δ and Grb14Δ lost in part the
ability to bind CaM when compared with their wild-
type counterparts, they still had, particularly Grb10,
significant CaM-binding capacity. In contrast, the dele-
tion mutant Grb7Δ almost completely lost this ability
(Fig. 1B).
Table 1. Sequence homology of the canonical CaM-BD of Grb7 family members.
Protein CaM-BD residues CaM-BD sequence
CaM-BD
identity (%)
Whole sequence
identity (%) Reference
Grb7 (human) 243–256 RKLWKRFFCFLRRS – – [58]
Grb7V (human) 243–256               100 97 [12]
Grb7 (rat) 246–259               100 92 [37]
Grb7 (mouse) 246–259               100 90 [59]
Grb10c (human) 304–317 K s  KlYvc     58 55 [20]
Grb10b (human) 246–259 K s  KlYvc     58 55 [21]
Grb10a (human) N/A N/A N/A 49 [60]
Grb10a (mouse) 332–345   s   KlYvc     60 56 [61]
Grb10d (mouse) 307–320   s   KlYvc     60 49 [31]
Grb14 (human) 248–261 K s  KiYf     67 52 [36]
Grb14 (rat) 246–259 K s   KaYf     67 50 [37]
Grb14 (mouse) 246–259 K  s   KaYf      67 51 [62]
Mig10 (C. elegans) 358–371   s   KhYfv p  53 60 [7]
Identical amino acids are indicated as dots, conserved substitutions as capital letters and nonconserved substitutions as lower case letters.
CaM-BD, calmodulin-binding domain. The sequence identity of the CaM-BD and the whole protein are compared to human Grb7. The homol-
ogous CaM-BD sequence of the Mig10 protein from C. elegans is also included. The human Grb10a isoform lacks the region of the pleck-
strin homology domain where the CaM-BD is located due to alternative splicing (N/A).
Fig. 1. Isolation of the three Grb7 family members by Ca2+-dependent CaM-affinity chromatography and effect of deleting the proposed
CaM-BDs. (A) FLAG-tagged Grb7, HA-tagged Grb10 and FLAG-tagged Grb14 were transfected in HEK293 cells and their expression patterns
determined by western blot using anti-Grb7, anti-HA and anti-Grb14 antibodies to detect FLAG-tagged Grb7 and Grb7Δ, HA-tagged Grb10
and Grb10Δ, and FLAG-tagged Grb14 and Grb14Δ, respectively. (B) FLAG-tagged Grb7, FLAG-tagged Grb14, HA-tagged Grb10, and their
corresponding CaM-BD deletion mutants were transfected in HEK293 cells and their cytosolic fractions were processed by Ca2+-dependent
CaM-affinity chromatography. After loading, the columns were extensively washed (W) with the Ca2+-buffer to ascertain the absence of
unattached proteins. The EGTA-eluted fractions were processed by SDS/PAGE and western blot using anti-Grb7, anti-HA and anti-Grb14
antibodies to detect FLAG-tagged Grb7 and Grb7Δ, HA-tagged Grb10 and Grb10Δ, and FLAG-tagged Grb14 and Grb14Δ, respectively.
Samples of the cytosolic fractions (CF) were included to ascertain the positive detection of the proteins.
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To exclude that the adaptor proteins were piggy-
back bound to other CaM-BPs present in the prepara-
tions, we decided to estimate the binding and affinity
of peptides corresponding to the identified CaM-BDs
of Grb7, Grb10 and Grb14 to CaM. We used a new
technique based on fluorescence polarization to
describe the binding affinity of CaM for its target, as
well as the minimum number of Ca2+ bound to CaM
to achieve efficient binding [50,51]. Peptides corre-
sponding to the CaM-BD of Grb7, and the homolo-
gous sequences of Grb10 and Grb14 tagged with the
fluorescent probe TAMRA (Fig. 2A) were assayed by
fluorescent polarization of the CaM/peptide target
interaction. We used a titration matrix in which both
Ca2+ and CaM concentrations were changed to deter-
mine the minimum number of Ca2+ bound to CaM
that was required for the interaction to occur with effi-
ciency, as well as the apparent association and dissoci-
ation constants (K’a and K’d) [50,51]. Figure 2B shows
the apparent dissociation constants (K’d) of the fluo-
rescent target peptides corresponding to the CaM-BD
of Grb7, Grb10 and Grb14 when they bind to CaM as
a function of the Ca2+ concentration. The peptide cor-
responding to the CaM-BD of Grb7 presented higher
affinity for CaM (as given by a lower K’d) than the
Grb14 peptide, while the affinity for CaM of the pep-
tide corresponding to the potential CaM-BD of Grb10
was even lower than the latter.
CaM is able to bind up to four Ca2+, and the asso-
ciation constants of Ca2+ to the different binding sites
were used to obtain the apparent association constant
(K’a) of the peptides when bound to CaM in the
absence of Ca2+ and at different Ca2+ saturations, as
described in Table 2 for apo-CaM (A), CaM-Ca2+
(B), CaM-2Ca2+ (C) CaM-3Ca2+ (D) and CaM-
4Ca2+ (E). With this information, it was determined
the minimum number of Ca2+ required to generate a
conformational change in CaM to trigger effective
binding to the peptides. In all cases, we found that this
change occurred when a single Ca2+ was bound to
CaM, but in the case of the Grb7 peptide the affinity
further increased upon additional Ca2+ binding sites
were saturated. Overall, these experiments confirmed
that all the Grb7 family members are CaM-BPs and
that the identified CaM-BD sequences are essential or
contributed to Ca2+-dependent CaM binding. How-
ever, their relative affinities for CaM were different,
resulting in the following sequence: Grb7 > > Grb14
> Grb10.
Since Grb10Δ showed significant residual capacity
to bind CaM (Fig. 1A), we searched for additional
site(s) that could contribute to CaM binding.
Although with low scores, we identified two additional
sites with the sequences 246RKNYAKYEFFKN257
and 387RTCWMTAFRLLK398. We prepared addi-
tional Grb10 deletion mutants lacking these new sites,
denoted, respectively, Grb10Δ1 and Grb10Δ3; and
assigning to the original mutant lacking the site
304KKSWKKLYVCLRRS317 used in Fig. 1, that has
higher homology to the CaM-BD of Grb7, the new
name Grb10Δ2. In addition, we prepared the double
deletion mutants Grb10Δ1Δ2 and Grb10Δ2Δ3.
Fig. 2. Binding of CaM to TAMRA-labeled
peptides corresponding to the CaM-BDs of
Grb7, Grb10 and Grb14 at different Ca2+
concentrations. (A) Sequence of the
TAMRA-labeled peptides corresponding to
the CaM-BDs of Grb7, Grb10 and Grb14.
The chemical structure of TAMRA is also
shown. (B) The plot presents the apparent
dissociation constant (K’d) of the Grb7,
Grb10 and Grb14 peptides bound to CaM
at different concentrations of free Ca2+.
Table 2. Association constants of CaM with different degrees of
Ca2+ saturation for CaM-BD peptides of the three Grb7 family
members.
CaM-BD
peptide A (lM1) B (lM1) C (lM1) D (lM1) E (lM1)
Grb7 3.3 293.9 391.9 391.9 391.9
Grb10 0.02 6.4 6.4 6.4 6.4
Grb14 0.13 36.5 36.5 36.5 36.5
Association constants of CaM for peptides corresponding to the
CaM-BDs of Grb7, Grb10 and Grb14 at different degrees of Ca2+
saturation. A, B, C, D and E are the association constant for apo-
CaM, CaM-1Ca2+, CaM-2Ca2+, CaM-3Ca2+ and CaM-4Ca2+, respec-
tively.
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Figure 3A shows the expression pattern of this bat-
tery of Grb10 deletion mutants in transfected HEK293
cells, where a slight increase in electrophoretic mobility
was apparent as expected, with the lowest mobility
change corresponding to Grb10Δ3. We then deter-
mined the ability of all these mutants to interact with
CaM using Ca2+-dependent CaM-affinity chromatog-
raphy. Figure 3B shows that Grb10Δ1, and particu-
larly Grb10Δ3, strongly decreased or lost, respectively,
the capacity to bind CaM, as compared to Grb10Δ2.
Similar results were found using the double deletion
mutants Grb10Δ1Δ2 and Grb10Δ2Δ3 as expected.
Discussion
The mammalian Grb7 protein family formed by Grb7,
Grb10 and Grb14 shares a conserved structure with
high sequence homology [1–6]. We have previously
described human Grb7 and its variant Grb7V as
CaM-BPs that bind CaM in a Ca2+-dependent man-
ner both in vitro and in living cells [17]. In this work,
we aimed to test whether the other members of the
Grb7 family, Grb10 and Grb14, were also able to
interact with CaM. As shown in Table 1, sequence
alignment showed that Grb10 and Grb14 might con-
tain CaM-BDs homologues to the one in Grb7, com-
prising the sequences 246KKSWKKLYVCLRRS259 in
hGrb10b, 304KKSWKKLYVCLRRS317 in hGrb10c
and 248KKSWKKIYFFLRRS261 in hGrb14. We
demonstrated using CaM-affinity chromatography that
both hGrb10c and hGrb14 were able to bind CaM in
a Ca2+-dependent manner. The fact that the Grb10
and Grb14 deletion mutants in these domains did not
completely lose their ability to bind CaM suggested
the possibility of alternative or additional CaM-BDs
present in these proteins.
We have run in silico CaM-BD prediction and no
other amphiphilic a-helix domain or any potential IQ
motif were found in these proteins. In contrast to Grb7,
where direct interaction with CaM was detected in vitro
by CaM-affinity chromatography, CaM-overlay experi-
ments and in living cells by FRET [17]; at first, we could
not discard that Grb10 and/or Grb14 could be
piggy-back bound to unidentified CaM-BPs during the
chromatographic process. To determine whether the
proposed sequences had the capacity to bind CaM, we
determined the binding and affinity of fluorescent-
tagged peptides corresponding to the CaM-BDs of
hGrb7, hGrb10c and hGrb14 to CaM in the presence of
different concentrations of Ca2+. Despite the high
homology sequence shown between the three Grb7 pro-
tein family members, the affinity of these peptides for
CaM was different, being the CaM-BD of Grb7 the one
presenting the highest affinity while the one correspond-
ing to the CaM-BD of Grb10 showed the lowest one,
suggesting that structural differences might be found in
these domains. As it has been previously described, sev-
eral isoforms of hGrb10, generated by alternative splic-
ing, have been identified, including hGrb10a, hGrb10b
and hGrb10c [2]. They basically differ in their PH
domain, where the CaM-BD is located. The hGrb10b
and hGrb10c isoforms show high homology sequence
between their putative CaM-BDs and the one of hGrb7
(Table 1), whereas, the hGrb10a isoform lacks the seg-
ment harboring the sequence corresponding to the
CaM-BD present in the other isoforms.
Typical CaM-BDs form basic amphiphilic a-helixes
with basic and hydrophobic residues exposed at
Fig. 3. Isolation of Grb10 by Ca2+-dependent CaM-affinity chromatography and effect of deleting several sequence segments. (A) HA-
tagged Grb10 and the deletion mutants Grb10Δ1, Grb10Δ2, Grb10Δ3, Grb10Δ1Δ2 and Grb10Δ2Δ3 were transfected in HEK293 cells and
their expression patterns determined by western blot using an anti-Grb10 antibody. (B) HA-tagged Grb10, and the indicated deletion
mutants were transfected in HEK293 cells and their cytosolic fractions were processed by Ca2+-dependent CaM-affinity chromatography.
After loading, the columns were extensively washed (W) with the Ca2+-buffer to ascertain the absence of unattached proteins. The EGTA-
eluted fractions were processed by SDS/PAGE and western blot using an anti-HA antibody. Samples of the cytosolic fractions (CF) were
included to ascertain the positive detection of the proteins.
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opposite sides of the helix [52]. Although in the pre-
dicted helical projections of the CaM-BDs of hGrb7,
hGrb10b/hGrb10c and hGrb14, there is a noticeable
segregation of basic and hydrophobic amino acids at
opposite sides of all the helixes, the helix corresponding
to the CaM-BD of Grb7 is the one showing a more uni-
form distribution, followed by the one corresponding to
the CaM-BD of Grb14 and in lesser extent the one cor-
responding to the CaM-BD of hGrb10b/hGrb10c. This
suggests that the CaM-BD of Grb7 would be the one
presenting higher affinity for CaM, followed by the
CaM-BDs of Grb14 and Grb10 as our results show.
Crystallographic studies of the resolved PH domain of
hGrb10b, where the CaM-BD is located, have shown
that it is structured as a b-strand within a b-sheet [53]
instead of an a-helix. This could be the reason why the
affinity of the peptide corresponding to the CaM-BD of
Grb10 shows the lowest affinity for CaM, as compare to
the other Grb7 family members. The lack of crystallo-
graphic structures of the whole proteins, however, pre-
vents us to establish whether or not the identified CaM-
BDs form a-helixes or not in its native forms. Neverthe-
less, in the case of Grb10, our results show that two
additional sites, upstream and downstream of the
canonical CaM-BD with sequence similarity to the
CaM-BD of Grb7, play an essential role in CaM bind-
ing, as its absence drastically impairs Ca2+-dependent
CaM binding. We could not identify in Grb14 addi-
tional sites with high score to be potential CaM-BD,
although it cannot be discarded its existence due to the
intrinsic uncertainty of the predicting software. Yet, we
cannot exclude the existence in this protein of other
accessory site(s) contributing to CaM binding. It is
likely that conformational changes in the structure of
these mutant proteins could contribute to the loss of
their CaM-binding capacity.
As we have previously described, the minimum
number of Ca2+ bound to CaM required to induce an
effect depends on the target protein and might vary
from protein to protein, offering extra regulatory
mechanisms [43,47,51,54]. We found specific recogni-
tion of CaM for the CaM-BD peptides of Grb7,
Grb10 and Grb14, when CaM had a single Ca2+
bound, suggesting that although the affinity for CaM
is different, the recognition mechanism appears to be
very similar. Nevertheless, in the case of Grb7, the
affinity for CaM increased upon binding of the second
Ca2+ (Table 2). In contrast, using an analogous
approach, it was found that a peptide corresponding
to the CaM-BD of the EGFR, also previously
described by our laboratory as a CaM-BP [55–57], pre-
sented the highest affinity for the Ca2+-CaM complex
when 4 Ca2+ were bound to CaM [51].
Future work should be performed to determine the
functional roles of the identified CaM-BDs of Grb10
and Grb14. As the different Grb10 isoforms differ in
their expression pattern in a tissue-specific manner
[23], it would be interesting to study whether there is
connection between this differential expression pattern
and the effect that CaM could play regulating the iso-
forms that contain a CaM-BD (hGrb10b, hGrb10c) in
contrast to the hGrb10a isoform lacking this domain.
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